Mamedica
Mamedica is an independent, private clinic and pharmacy founded with a focus on giving patients maximum choice across premium craft cultivars and lifetime fee waivers.
Verified 2026 Fee Schedule & Pricing
Verified Official DataMamedica Access Scheme
A one-time £200 payment covering all initial assessments, all follow-ups, and all repeat prescription fees for life for armed forces veterans, blue light card holders, students 18+, and patients on means-tested government benefits (PIP, DLA, Universal Credit, ESA).
MCRx Clinical & Patient Review
Overview & Clinical Governance
Mamedica has established a dedicated patient following by championing an open formulary and transparent, patient-centric prescribing. Rather than pushing single-brand house medications, Mamedica doctors collaborate closely with patients to identify the precise terpene and cannabinoid profiles that suit their symptoms.
Consultation Experience
Mamedica consultations are compassionate, unhurried, and highly detailed. Clinicians are well-versed in both psychiatric and somatic indications, allowing patients to openly discuss their prior experience with cannabis and desired therapeutic outcomes.
Pricing Transparency
Mamedica operates on an upfront investment model. While standard Year 1 costs (£375 total) are higher upfront, Year 2+ clinic fees drop to £0. For anyone eligible for the Access Scheme, the £200 lifetime fee makes Mamedica arguably the single most cost-effective clinic in the UK over a 2–5 year horizon.
Product & Cultivar Availability
Mamedica maintains direct stock relationships with major international cultivators (Aurora, Lot420, Green Karat, Peace Naturals, Lumir, Big Narstie Medical). Their patient portal displays live cultivar availability, reducing out-of-stock rewrite delays.
Key Strengths
- Mamedica Access Scheme (£200 lifetime) offers unbeatable long-term value for eligible patients
- £0 ongoing clinic consultation fees after Year 1 on standard plans
- Complete open-formulary approach with access to top-tier Canadian, Australian, and German craft flowers
- Dedicated in-house patient portal for frictionless repeat requests and stock browsing
Potential Drawbacks
- Higher Year 1 entry cost on standard plan (£150 initial + £75 reviews) compared to monthly subscription clinics
- £15 administrative fee applies if requesting medication changes outside of scheduled consultations
Recommended Hardware & Administration Gear for Mamedica Patients
MHRA-compliant dry herb vaporizers, ergonomic arthritis-friendly grinders, and microdosing tools
Mighty+ Medic Vaporizer
The gold standard in UK medical cannabis administration. The Mighty+ Medic is officially certified as a CE/UKCA medical device, delivering consistent, highly potent vapor with medical-grade precision.
DynaVap M7 & M7 XL
A 100% medical-grade stainless steel thermal extraction device (TED). Produces thick, flavorful vapor from tiny microdoses (0.05g – 0.1g) using a torch or induction heater. Features an acoustic bimetallic thermostat cap that clicks when vapor temperature is reached.
Krush Kube 2.0 / 3.0 Ergonomic Grinder
Engineered specifically for patients with reduced grip strength, arthritis, or hand tremors. The unique square curved silhouette provides effortless leverage, while innovative tooth geometry creates two distinct grind consistencies (fluffy for convection vs fine for conduction).
Frequently Asked Questions: Mamedica
Who qualifies for the Mamedica Access Scheme?
The Mamedica Access Scheme is open to military veterans, Blue Light Card holders (police, NHS, fire service), full-time students aged 18+, and individuals receiving qualifying government benefits (PIP, DLA, Universal Credit, Employment and Support Allowance).
Are there really £0 consultation fees after Year 1?
Yes. On Mamedica’s standard pathway, once you have completed your initial onboarding and mandatory Year 1 check-ins (months 1, 3, and 6), routine consultations in Year 2 and beyond are free of charge.
Can I switch my prescribed strain without booking a full appointment?
Yes. Mamedica allows patients to request strain changes through their portal for a nominal £15 administration rewrite fee, provided the THC percentage and quantity remain within the doctor’s authorized allowance.
MCRx is an independent patient resource and is not commercially affiliated with Mamedica. Fee structures, appointment cadences, and formulary access are compiled directly from public clinic disclosures verified for 2026. If you notice any updated fees or policy changes, please submit a correction to [email protected].